Publikasi Scopus Covid-19 Per 14 Agustus 2024 (559 artikel)

Farhoudian A., Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Radfar S.R., Department of Neuroscience and Addiction, School of Advanced Technologies in Medicine (SATiM), Tehran University of Medical Sciences, Tehran, Iran, Integrated Substance Abuse Programs Department, University of California, Los Angeles, Los Angeles, CA, United States; Ardabili H.M., Psychiatry and Behavioral Sciences Research Center, Faculty of Medicine, Ibn-e-Sina Hospital, Mashhad University of Medical Sciences, Mashhad, Iran, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; Rafei P., Department of Psychology, Faculty of Psychology and Education, University of Tehran, Tehran, Iran, Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Ebrahimi M., Iranian National Center for Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran; Zonoozi A.K., Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran; De Jong C.A.J., Behavioral Science Institute, Radboud University, Nijmegen, Netherlands; Vahidi M., Department of Psychiatry, Tehran University of Medical Sciences, Tehran, Iran; Yunesian M., School of Public Health, Tehran University of Medical Sciences, Tehran, Iran; Kouimtsidis C., Surrey and Borders Partnership National Health Service Foundation Trust, Leatherhead, United Kingdom; Arunogiri S., Turning Point, Eastern Health, Box Hill, VIC, Australia; Hansen H., Departments of Anthropology and Psychiatry, New York University, New York, NY, United States; Brady K.T., Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, United States; Potenza M.N., Yale School of Medicine, Connecticut Council on Problem Gambling and Connecticut Mental Health Center, New Haven, CT, United States; Baldacchino A.M., Division of Population and Behavior Sciences, Medical School, University of St Andrews, St Andrews, United Kingdom; Ekhtiari H., Laureate Institute for Brain Research, Tulsa, OK, United States; Abagiu A.O., National Institute for Infectious Diseases, Prof. Dr. Matei Bals-Arena OMT Department, Romania; Abouna F.D.N., Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Cameroon; Ahmed M.H., Alamal psychiatric hospital, Dubai, United Arab Emirates; Al-Ansari B., Sydney Medical School, University of Sydney, NSW, Australia; Al-Khair F.M.A., Al Ahliyya Amman University, Amman, Jordan; Almaqbali M.H., Ministry of Health, Muscat, Oman; Ambekar A., Department of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Arya S., State Drug Dependence Treatment Centre, Institute of Mental Health, Pt BDS University of Health Sciences, India; Asebikan V.O., Department of Psychiatry, College of Medicine, University of Ibadan, Nigeria; Ayasreh M.A., Addiction Medicine Clinic, Jordan; Basu D., Drug De-addiction and Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Benmebarek Z., Addiction Medicine Clinic, Mila, Algeria; Bhad R., Department of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Blaise M., Centre medical Marmottan, France; Bonnet N., Réseau de Prévention des Addictions (RESPADD), France; Brasch J., Department of Psychiatry and Behavioural Neurosciences, Michael DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada; Broers B., Geneva University Hospitals, Switzerland; Busse A., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Butner J.L., CUNY School of Medicine, New York, United States; Camilleri M., Agenzija Sedqa, Malta; Campello G., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Carra G., Department of Medicine and Surgery, University Milan-Bicocca, Italy; Celic I., University Psychiatric Hospital Vrapce-Zagreb, Croatia; Chalabianloo F., Department of Addiction Medicine, Haukeland University Hospital, Bergen, Norway; Chaturvedi A., Department of Biochemistry, Melaka Manipal Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India; Cherpitel J.J.E.N., Addiction Medicine Clinic, Mexico; Clark K.J., Addiction Crisis Solutions, United States; Cyders M.A., Department of Psychology, Indiana University Purdue University-Indianapolis, United States; de Bernardis E., SerT Lentini, ASP Siracusa, Italy; Deilamizade A., Rebirth Charity Society NGO, Tehran, Iran; Derry J.E., Serenity Vista Addiction Treatment Center, Panama; Dhagudu N.K., Department of Psychiatry, ESIC Medical College, Hyderabad, Telangana, India; Dolezalova P., National Institute of Mental Health, Czech Republic; Dom G., Collaborative Antwerp Psychiatric Research Institute (CAPRI), Antwerp University (UA), Belgium; Dunlop A.J., Drug & Alcohol Clinical Services, Hunter New England Local Health District, Australia; Elhabiby M.M., Ain Shams University, Cairo, Egypt; Elkholy H., Department of Neurology and Psychiatry, Faculty of Medicine, Ain Shams University, Cairo, Egypt; Essien N.F., Centre for Research and Information on Substance Abuse, Nigeria; Farah G.I., Addiction Medicine Clinic, Syrian Arab Republic; Ferri M., European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Italy; Floros G.D., Department of Psychiatry, Aristotle University of Thessaloniki, Greece; Friedman C., Brown University and Lifespan Health System, Providence, RI, United States; Fuderanan C.H., Fuderanan Mental Health Clinic, Philippines; Gerra G., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Ghosh A., Drug De-addiction & Treatment Centre, Department of Psychiatry, Postgraduate Institute of Medical Education & Research, Chandigarh, India; Gogia M., Georgian Harm Reduction Network, Georgia; Grammatikopoulos I.A., Organization Against Drugs, Primary Care Health Center, Veria, Greece; Grandinetti P., Addictions Services (Ser.D.), Department of Territorial Services, ASL Teramo, Italy; Guirguis A., Swansea University Medical School, Institute of Life Sciences 2, Singleton Campus, SA2 8PP, United Kingdom; Gutnisky D., Universidad de Buenos Aires, Argentina; Haber P.S., University of Sydney, Australia; Hassani-Abharian P., Institutes for Cognitive Science Studies (IRICSS), Brain and Cognition Clinic, Tehran, Iran; Hooshyari Z., Tehran University of Medical Sciences, Tehran, Iran; Ibrahim I.I.M., Ain Shams University, Cairo, Egypt; Ieong H.F.-H., Department of Anesthesiology, Yale University, United States; Indradewi R.N., Drugs Rehabilitation Center, National Narcotics Board of Indonesia, Indonesia; Iskandar S., Department of Psychiatry, Universitas Padjadjaran, Bandung, West Java, Indonesia; Isra T.N., National Institute of Education, Sri Lanka; Jain S., Department of Psychiatry, Heritage Institute of Medical Sciences (HIMS), Varanasi, India; James S., Univeristi Malaysia Sabah, Malaysia; Javadi S.M.H., Department of Social Work, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran; Joe K.H., National Center for Mental Health of Korea, South Korea; Jokubonis D., Republican Center for Addictive Disorders, Lithuania; Jovanova A.T., Addiction Medicine Clinic, North Macedonia; Kamal R.M., Naufar Institute, Doha, Qatar; Kantchelov A.I., The Kantchelov Clinic, Sofia, Bulgaria; Kathiresan P., Department of Psychiatry and National Drug Dependence Treatment Centre (NDDTC), All India Institute of Medical Sciences (AIIMS), New Delhi, India; Katzman G., Mount Sinai Medical Center, New York, United States; Kawale P., African Institute for Development Policy, Malawi; Kern A.M., Sobriety Centers of New Hampshire, United States; Kessler F.H.P., Federal University of Rio Grande do Sul, Brazil; Kim S.-G.S., Pusan National University Yangsan Hospital, Department of Neuropsychiatry, Yangsan, South Korea; Kimball A.M., Chatham House, United States; Kljucevic Z., Institute for Public Health of Split-Dalmatia County, Croatia; Kurniasanti K.S., Faculty of Medicine, Universitas Indonesia-Ciptomangunkusumo Hospital, Indonesia; Lev R., Scripps Mercy Hospital, San Diego, United States; Lee H.K., Department of Psychiatry, The Catholic University of Korea, Seoul, South Korea; Lengvenyte A., Faculty of Medicine, Institute of Clinical Medicine, Psychiatric Clinic, Vilnius University, Vilnius, Lithuania; Lev-Ran S., Israel Center on Addiction, Netanya, Israel; Mabelya G.S., Community Health Work, Tanzania; Mahi M.A.E., Hayat Center for Treatment and Psycho-social Rehabilitation, Khartoum, Sudan; Maphisa J.M., University of Botswana, Botswana; Maremmani I., V.P. Dole, Dual Disorder Unit, Santa Chiara University Hospital, University of Pisa, Italy; Masferrer L., CAS Girona, Department of Psychology, University of Girona, Spain; Massah O., Substance Abuse and Dependence Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran; McCambridge O., Community addiction team, Southern Health and Social Care Trust, United Kingdom; McGovern G.G., Priority Medical Clinic, Dublin, Ireland; Min A.K., Save the Children International Organization, Burma; Moghanibashi-Mansourieh A., Department of Social Work, University of Social Welfare & Rehabilitation Sciences, Tehran, Iran; Mora-Rios J., Dirección de Investigaciones Epidemiológicas y Sociales, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, United States; Mudalige I.U.K., Department of Psychiatry, Faculty of Medicine, Sir John Kotelawala Defence University, Sri Lanka; Mukherjee D., Centre for Addiction Medicine, NIMHANS, Bangalore, India; Munira P.M., Kleopatra Kodric, Irena Nisic, Slovenia; Myers B., Alcohol Tobacco and Other Drug Research Unit, South African Medical Research Council, South Africa; Menon T. N. J., NIMHANS, Bangalore, India; Narasimha V.L., Centre for Addiction Medicine, Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bengaluru, India; Ndionuka N., Federal Neuropsychiatric Hospital, Calabar, Nigeria; Nejatisafa A.-A., Department of Psychiatry, Psychosomatic Research Center, Tehran University of Medical Sciences, Tehran, Iran; Niaz K., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Nizami A.T., Institute of Psychiatry, WHO Collaborating Center for Mental Health, Pakistan; Nuijens J.H., Brijder Addiction Care, Zaandam, Netherlands; Orsolini L., Department of Clinical Neurosciences/DIMSC, School of Medicine, Polytechnic University of Marche, Ancona, Italy; Oum V., Koh Kong Provincial Hospital, Cambodia; Oyemade A.A., Kaiser Permanente, United States; Palavra I.R., Psychiatric hospital Sveti Ivan, Zagreb, Croatia; Pant S.B., Department of Psychiatry and mental health, Institute of Medicine, Tribhuvan University, Nepal; Paredes J., Universidad de El Salvador, El Salvador; Peyron E., AddiPsy, Lyon, France; Quirós R.A., Addiction Medicine Clinic, Costa Rica; Qurishi R., Novadic-Kentron Addiction Care Network, Vught, Netherlands; Rafiq N.U.Z., Phoenix Foundation for Research and Development, Pakistan; Raghavendra Rao R., Barwon Health, Geelong, Australia; Ratta-Apha W., Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand; Raymond K.-L., University of the Sunshine Coast (USC), QLD, Australia; Reimer J., Center for Interdisciplinary Addiction Research, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Renaldo E., Drugs Rehabilitation Center, National Narcotics Board of Indonesia; Rezapour T., Department of Cognitive Psychology, Institute for Cognitive Science Studies, Tehran, Iran; Robertson J.R., Usher Institute, University of Edinburgh, United Kingdom; Roncero C., Psychiatry Service, University of Salamanca Health Care Complex, Salamanca, Spain; Roub F., PGIMER, Chandigarh, India; Rubenstein E.J., Street Health Centre, Canada; Rupp C.I., Department of Psychiatry, Psychotherapy, and Psychosomatics, Medical University Innsbruck, Austria; Saenz E., United Nations Office on Drugs and Crime (UNODC), Vienna, Austria; Salehi M., Department of Neurosciences and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran; Samartzis L., Medical School, University of Cyprus, Cyprus; Sarubbo L.B., Clínica Psiquiátrica de la Facultad de Medicina, Uruguay; Segrec N., Center for Treatment of Drug addiction, University Psychiatric Clinic, Ljubljana, Slovenia; Shah B., Department of Psychiatry, Patan Academy of Health Sciences, School of Medicine, Lagankhel, Nepal; Shen H., Department of Psychiatry, Second Xiangya Hospital, Central South University, China; Shirasaka T., Department of Psychiatry, Teine Keijinkai Medical Center, Japan; Shoptaw S., David Geffen School of Medicine at UCLA, Department of Family Medicine, United States; Sintango F.M., Health Professions Councils of Namibia, Namibia; Sosa V.A., Addiction Medicine Clinic, Uruguay; Subata E., Republican Center for Addictive Disorders, Lithuania; Sztycberg N., Asociasion Programa Andres Argentina, Argentina; Taghizadeh F., Mazandaran University of Medical Sciences, Mazandaran, Iran; Wee Teck J.B.T., MRC/CSO SPHSU, University of Glasgow, United Kingdom; Tjagvad C., Gladsaxe Substance Use Disorder Treatment Centre, Denmark; Torrens M., Institut de Neuropsiquiatria i Addiccions, IMIM-Hospital del Mar, Medical Research, Barcelona, Spain; Twala J.M., NACADA, Kenya; Vadivel R., Waikato District Health Board (WDHB, Hamilton, New Zealand; Volpicelli J.R., Institute of Addiction Medicine, United States; Weijs J., Jellinek, Amsterdam, Netherlands; Wintoniw S.M., Addictions Foundation of Manitoba, Canada; Wittayanookulluk A., Thanyarak Chiangmai Hospital, Thailand; Wojnar M., Medical University of Warsaw, Warsaw, Poland; Yasir S., Institute of Psychiatry, WHO Collaborating Center for Mental Health, Pakistan; Yitayih Y., Jimma University, Ethiopia; Zhao M., Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, China